The Companies and Markets Show: Insurers, weight-loss drugs and survivor shares
This episode of The Companies and Markets Show begins with a dive into this week’s results from big players in the insurance industry, Aviva and Legal & General. Our deputy companies editor, Julian Hofmann, explains the market reaction to the businesses’ figures and highlights areas where they may be limited. Alex…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from Investors' Chronicle
See all episodes →
Similar episodes from other shows
More like Investors' Chronicle →
Investing in weight-loss drugs, and why everyone’s talking about student loans
Novo Nordisk, Eli Lilly and the GLP-1 economy
Novo Nordisk hits back at copycat drugs
Money Talks: Why weight-loss drugs will reshape the world
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.